市場調查報告書

全球異位性皮膚炎治療藥市場:產業分析,規模,佔有率,成長,趨勢,及預測(2019年∼2027年)

Atopic Dermatitis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

出版商 Transparency Market Research 商品編碼 920473
出版日期 內容資訊 英文 145 Pages
商品交期: 最快1-2個工作天內
價格
全球異位性皮膚炎治療藥市場:產業分析,規模,佔有率,成長,趨勢,及預測(2019年∼2027年) Atopic Dermatitis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027
出版日期: 2019年10月12日內容資訊: 英文 145 Pages
簡介

本報告提供全球異位性皮膚炎治療藥市場的相關調查,提供市場機會,成長及阻礙因素,藥物類別·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 市場定義·範圍
  • 市場區隔
  • 主要的調查目的
  • 調查亮點

第2章 前提條件·調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
    • 定義
  • 概要
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 市場分析·預測

第5章 市場預測

  • 疾病流行病學
  • 開發平台分析
  • 最近的開發

第6章 市場分析:各類藥物

  • 概要·定義
  • 市場銷售額預測
    • 皮質類固醇
    • PDE4抑制劑
    • 生技藥品
    • 皮膚屏障潤膚劑
    • CNI免疫抑制劑
    • 其他
  • 市場魅力

第7章 市場分析:各流通管道

  • 概要·定義
  • 市場銷售額預測
    • 醫院藥局
    • 零售藥局
    • 線上藥局
  • 市場魅力

第8章 市場分析:各地區

  • 主要調查結果
  • 市場銷售額預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力

第9章 北美

第10章 歐洲

第11章 亞太地區

第12章 南美

第13章 中東·非洲

第14章 競爭情形

  • 企業簡介
    • Mylan NV
    • Pfizer, Inc.
    • LEO Pharma A/S
    • Teva Pharmaceutical Industries Ltd
    • Sanofi
    • Novartis AG
目錄

Atopic Dermatitis Drugs Market: Scope of the Study

A new study on the global atopic dermatitis drugs market was published by Transparency Market Research (TMR). It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the atopic dermatitis drugs market. TMR's study offers valuable information about the atopic dermatitis drugs market, to illustrate how the market is expected to expand during the forecast period of 2019-2027.

Key indicators of market growth, which include value chain as well as supply chain analysis, and compound annual growth rate (CAGR), are elucidated in TMR's study in a comprehensive manner. This data can help readers interpret the quantitative growth aspects of the atopic dermatitis drugs market for the forecast period.

An extensive analysis on leading market players' business strategies is also featured in TMR's study on the atopic dermatitis drugs market. This can help readers understand the principal factors to foresee growth in the atopic dermatitis drugs market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the atopic dermatitis drugs market, which is expected to guide market players in making apt decisions in the future.

Key Questions Answered in TMR's Atopic Dermatitis Drugs Market Study

What is the scope of growth of atopic dermatitis drug companies in the pharmaceutical drugs sector?

What is the estimated Y-o-Y growth of the atopic dermatitis drugs market from 2019 to 2027?

What is the influence of the changing trends in technologies on the atopic dermatitis drugs market?

Is North America likely to continue to remain the most profitable regional market for atopic dermatitis drug providers?

Which factors are expected to hamper the atopic dermatitis drugs market during the forecast period?

Which are the leading companies in the global atopic dermatitis drugs market?

Research Methodology

A unique research methodology is utilized by TMR to conduct comprehensive research on the growth of the atopic dermatitis drugs market, and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the production of the atopic dermatitis drugs market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the atopic dermatitis drugs market, as a primary resource.

These primary and secondary resources provided exclusive information during the interviews, which serves as a validation from the atopic dermatitis drugs market industry leaders. Access to an extensive internal repository and external proprietary databases allows for this report to address specific details and questions about the atopic dermatitis drugs market with accuracy. The study also uses a top-down approach to assess the numbers for each segment, and a bottom-up approach to counter-validate them. This has helped in making TMR's estimates on the future prospects of the atopic dermatitis drugs market more reliable and accurate.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Atopic Dermatitis Drugs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Atopic Dermatitis Drugs Market Analysis and Forecasts, 2017-2027

5. Market Outlook

  • 5.1. Disease Epidemiology
  • 5.2. Pipeline Analysis
  • 5.3. Recent Development

6. Global Atopic Dermatitis Drugs Market Analysis and Forecasts, by Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Market Value Forecast by Drug Class, 2017-2027
    • 6.2.1. Corticosteroids
    • 6.2.2. PDE4 Inhibitors
    • 6.2.3. Biologics
    • 6.2.4. Skin Barrier Emollients
    • 6.2.5. CNI Immunosuppressants
    • 6.2.6. Others
  • 6.3. Market Attractiveness by Drug Class

7. Global Atopic Dermatitis Drugs Market Analysis and Forecasts, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Market Value Forecast by Distribution Channel, 2017-2027
    • 7.2.1. Hospital Pharmacies
    • 7.2.2. Retail Pharmacies
    • 7.2.3. Online Pharmacies
  • 7.3. Market Attractiveness by Distribution Channel

8. Global Atopic Dermatitis Drugs Market Analysis and Forecasts, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness by Country/Region

9. North America Atopic Dermatitis Drugs Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. Market Value Forecast by Drug Class, 2017-2027
    • 9.2.1. Corticosteroids
    • 9.2.2. PDE4 Inhibitors
    • 9.2.3. Biologics
    • 9.2.4. Skin Barrier Emollients
    • 9.2.5. CNI Immunosuppressants
    • 9.2.6. Others
  • 9.3. Market Value Forecast by Distribution Channel, 2017-2027
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Value Forecast by Country, 2017-2027
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Drug Class
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country

10. Europe Atopic Dermatitis Drugs Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Market Value Forecast by Drug Class, 2017-2027
    • 10.2.1. Corticosteroids
    • 10.2.2. PDE4 Inhibitors
    • 10.2.3. Biologics
    • 10.2.4. Skin Barrier Emollients
    • 10.2.5. CNI Immunosuppressants
    • 10.2.6. Others
  • 10.3. Market Value Forecast by Distribution Channel, 2017-2027
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Value Forecast by Country/Sub-region, 2017-2027
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Drug Class
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Atopic Dermatitis Drugs Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Market Value Forecast by Drug Class, 2017-2027
    • 11.2.1. Corticosteroids
    • 11.2.2. PDE4 Inhibitors
    • 11.2.3. Biologics
    • 11.2.4. Skin Barrier Emollients
    • 11.2.5. CNI Immunosuppressants
    • 11.2.6. Others
  • 11.3. Market Value Forecast by Distribution Channel, 2017-2027
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail Pharmacies
    • 11.3.3. Online Pharmacies
  • 11.4. Market Value Forecast by Country/Sub-region, 2017-2027
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Drug Class
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Latin America Atopic Dermatitis Drugs Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Market Value Forecast by Drug Class, 2017-2027
    • 12.2.1. Corticosteroids
    • 12.2.2. PDE4 Inhibitors
    • 12.2.3. Biologics
    • 12.2.4. Skin Barrier Emollients
    • 12.2.5. CNI Immunosuppressants
    • 12.2.6. Others
  • 12.3. Market Value Forecast by Distribution Channel, 2017-2027
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
  • 12.4. Market Value Forecast by Country/Sub-region, 2017-2027
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Drug Class
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Atopic Dermatitis Drugs Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Market Value Forecast by Drug Class, 2017-2027
    • 13.2.1. Corticosteroids
    • 13.2.2. PDE4 Inhibitors
    • 13.2.3. Biologics
    • 13.2.4. Skin Barrier Emollients
    • 13.2.5. CNI Immunosuppressants
    • 13.2.6. Others
  • 13.3. Market Value Forecast by Distribution Channel, 2017-2027
    • 13.3.1. Hospital Pharmacies
    • 13.3.2. Retail Pharmacies
    • 13.3.3. Online Pharmacies
  • 13.4. Market Value Forecast by Country/Sub-region, 2017-2027
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Drug Class
    • 13.5.2. By Distribution Channel
    • 13.5.3. By Country/Sub-region

14. Competitive Landscape

  • 14.1. Company Profiles
    • 14.1.1. Mylan N.V.
      • 14.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.1.2. Product Portfolio
      • 14.1.1.3. SWOT Analysis
      • 14.1.1.4. Strategic Overview
      • 14.1.1.5. Financial Overview
    • 14.1.2. Pfizer, Inc.
      • 14.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.2.2. Product Portfolio
      • 14.1.2.3. SWOT Analysis
      • 14.1.2.4. Strategic Overview
      • 14.1.2.5. Financial Overview
    • 14.1.3. LEO Pharma A/S
      • 14.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.3.2. Product Portfolio
      • 14.1.3.3. SWOT Analysis
      • 14.1.3.4. Strategic Overview
      • 14.1.3.5. Financial Overview
    • 14.1.4. Teva Pharmaceutical Industries Ltd
      • 14.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.4.2. Product Portfolio
      • 14.1.4.3. SWOT Analysis
      • 14.1.4.4. Strategic Overview
      • 14.1.4.5. Financial Overview
    • 14.1.5. Sanofi
      • 14.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.5.2. Product Portfolio
      • 14.1.5.3. SWOT Analysis
      • 14.1.5.4. Strategic Overview
      • 14.1.5.5. Financial Overview
    • 14.1.6. Novartis AG
      • 14.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.6.2. Product Portfolio
      • 14.1.6.3. SWOT Analysis
      • 14.1.6.4. Strategic Overview
      • 14.1.6.5. Financial Overview

List of Tables

  • Table 01: Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 02: Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 03: Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 04: North America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 05: North America Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 06: North America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 07: Europe Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 08: Europe Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 09: Europe Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 10: Asia Pacific Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 11: Asia Pacific Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 12: Asia Pacific Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 13: Latin America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 14: Latin America Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 15: Latin America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 16: Middle East & Africa Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 17: Middle East & Africa Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 18: Middle East & Africa Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027

List of Figures

  • Figure 01: Global Atopic Dermatitis Drugs Market Snapshot
  • Figure 02: Global Atopic Dermatitis Drugs Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
  • Figure 03: Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 04: Global Atopic Dermatitis Drugs Market Value Share (%), by Drug Class (2018)
  • Figure 05: Global Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel (2018)
  • Figure 06: Global Atopic Dermatitis Drugs Market Value Share (%), by Region (2018)
  • Figure 07: Global Atopic Dermatitis Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 08: Global Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019-2027
  • Figure 09: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017-2027
  • Figure 10: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PDE4 Inhibitors, 2017-2027
  • Figure 11: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Biologics, 2017-2027
  • Figure 12: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Skin Barrier Emollients, 2017-2027
  • Figure 13: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CNI Immunosuppressants, 2017-2027
  • Figure 14: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2027
  • Figure 15: Global Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 16: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017-2027
  • Figure 17: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017-2027
  • Figure 18: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017-2027
  • Figure 19: Global Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 20: Global Atopic Dermatitis Drugs Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 21: Global Atopic Dermatitis Drugs Market Attractiveness, by Region, 2019-2027
  • Figure 22: North America Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 23: North America Atopic Dermatitis Drugs Market Value Share (%), by Country, 2018 and 2027
  • Figure 24: North America Atopic Dermatitis Drugs Market Attractiveness, by Country, 2019-2027
  • Figure 25: North America Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 26: North America Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019-2027
  • Figure 27: North America Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 28: North America Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 29: Europe Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 30: Europe Atopic Dermatitis Drugs Market Value Share (%), by Country/Sub-region, 2018 and 2027
  • Figure 31: Europe Atopic Dermatitis Drugs Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 32: Europe Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 33: Europe Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019-2027
  • Figure 34: Europe Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 35: Europe Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 36: Asia Pacific Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 37: Asia Pacific Atopic Dermatitis Drugs Market Value Share (%), by Country/Sub-region, 2018 and 2027
  • Figure 38: Asia Pacific Atopic Dermatitis Drugs Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 39: Asia Pacific Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 40: Asia Pacific Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019-2027
  • Figure 41: Asia Pacific Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 42: Asia Pacific Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 43: Latin America Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016-2026
  • Figure 44: Latin America Atopic Dermatitis Drugs Market Value Share (%), by Country/Sub-region 2018 and 2027
  • Figure 45: Latin America Atopic Dermatitis Drugs Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 46: Latin America Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 47: Latin America Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019-2027
  • Figure 48: Latin America Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 49: Latin America Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 50: Middle East & Africa Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 51: Middle East & Africa Atopic Dermatitis Drugs Market Value Share (%), by Country/Sub-region 2018 and 2027
  • Figure 52: Middle East & Africa Atopic Dermatitis Drugs Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 53: Middle East & Africa Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 54: Middle East & Africa Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019-2027
  • Figure 55: Middle East & Africa Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 56: Middle East & Africa Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 57: Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018
  • Figure 58: Mylan N.V. R&D Expenses (US$ Mn), 2016-2018
  • Figure 59: Mylan N.V. Breakdown of Net Sales (%), by Region, 2018
  • Figure 60: Mylan N.V. Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 61: Pfizer, Inc. Breakdown of Net Sales, by Region, 2018
  • Figure 62: Pfizer, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2018
  • Figure 63: Pfizer, Inc. R&D Expenses (US$ Mn), 2016-2018
  • Figure 64: LEO Pharma A/S Breakdown of Net Sales, by Region (2018)
  • Figure 65: LEO Pharma A/S Breakdown of Net Sales, by Therapeutic Area (2018)
  • Figure 66: LEO Pharma A/S Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2018
  • Figure 67: LEO Pharma A/S R&D Expenses (US$ Mn), 2016-2018
  • Figure 68: Sanofi Revenue (US$ Bn), 2015-2018
  • Figure 69: Sanofi Regional Sales Breakdown (%), 2018
  • Figure 70: Novartis AG Breakdown of Net Sales, by Region, 2018
  • Figure 71: Novartis AG Breakdown of Net Sales, by Business Segment, 2018
  • Figure 72: Novartis AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2015-2018
  • Figure 73: Novartis AG R&D Expenses (US$ Mn), 2016-2018
  • Figure 74: Teva Pharmaceutical Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2018
  • Figure 75: Teva Pharmaceutical R&D Expenses (US$ Mn), 2016-2018
  • Figure 76: Teva Pharmaceutical Breakdown of Net Sales, by Region, 2018
  • Figure 77: Teva Pharmaceutical Breakdown of Net Sales, (Overall Company Level), 2018